andrea remo
andrea remo
AULSS9, Verona (Italy)
Verified email at
Cited by
Cited by
Genetic and epigenetic events generate multiple pathways in colorectal cancer progression
M Pancione, A Remo, V Colantuoni
Pathology research international 2012, 2012
Leptin/HER2 crosstalk in breast cancer: In vitro study and preliminary in vivoanalysis
E Fiorio, A Mercanti, M Terrasi, R Micciolo, A Remo, A Auriemma, ...
BMC cancer 8 (1), 1-11, 2008
Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification: Evaluation According to ASCO/CAP Criteria
M Brunelli, E Manfrin, G Martignoni, K Miller, A Remo, D Reghellin, ...
American journal of clinical pathology 131 (5), 678-682, 2009
Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis
M Pancione, G Giordano, A Remo, A Febbraro, L Sabatino, E Manfrin, ...
Journal of immunology research 2014, 2014
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy
M Brunelli, E Manfrin, G Martignoni, S Bersani, A Remo, D Reghellin, ...
American journal of clinical pathology 129 (6), 907-911, 2008
Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1
RS Arnold, J He, A Remo, D Ritsick, Q Yin-Goen, JD Lambeth, MW Datta, ...
The American journal of pathology 171 (6), 2021-2032, 2007
Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept
G Giordano, A Febbraro, M Venditti, S Campidoglio, N Olivieri, K Raieta, ...
Gastroenterology research and practice 2014, 2014
Role of molecular markers in diagnosis and prognosis of renal cell carcinoma.
G Martignoni, M Brunelli, S Gobbo, A Remo, V Ficarra, P Cossu-Rocca, ...
Analytical and quantitative cytology and histology 29 (1), 41-49, 2007
Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
G Giordano, A Febbraro, E Tomaselli, ML Sarnicola, P Parcesepe, ...
Journal of experimental & clinical cancer research 34 (1), 1-11, 2015
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases
E Manfrin, A Remo, F Falsirollo, D Reghellin, F Bonetti
Breast cancer research and treatment 107 (3), 371-377, 2008
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor
R Zanotti, A Ambrosetti, M Lestani, P Ghia, C Pattaro, A Remo, F Zanetti, ...
Leukemia 21 (1), 102-109, 2007
Expression of aromatase and estrogen receptors in human adrenocortical tumors
L Barzon, G Masi, M Pacenti, M Trevisan, F Fallo, A Remo, G Martignoni, ...
Virchows Archiv 452 (2), 181-191, 2008
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal.
A Remo, M Fassan, G Lanza
Pathologica 108 (3), 104-109, 2016
Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling
SM Pagnotta, C Laudanna, M Pancione, L Sabatino, C Votino, A Remo, ...
PloS one 8 (8), e72638, 2013
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
A Remo, I Simeone, M Pancione, P Parcesepe, P Finetti, L Cerulo, ...
Journal of translational medicine 13 (1), 1-13, 2015
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions
SF Crinò, L Bernardoni, L Brozzi, L Barresi, G Malleo, R Salvia, L Frulloni, ...
Gastrointestinal endoscopy 90 (6), 933-943, 2019
Morphology and molecular features of rare colorectal carcinoma histotypes
A Remo, M Fassan, A Vanoli, LR Bonetti, V Barresi, F Tatangelo, R Gafà, ...
Cancers 11 (7), 1036, 2019
Benign breast lesions at risk of developing cancer—A challenging problem in breast cancer screening programs: Five years' experience of the Breast Cancer Screening Program in …
E Manfrin, R Mariotto, A Remo, D Reghellin, F Falsirollo, D Dalfior, ...
Cancer 115 (3), 499-507, 2009
t (6; 11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid …
A Caliò, M Brunelli, D Segala, S Pedron, R Tardanico, A Remo, S Gobbo, ...
Modern Pathology 31 (3), 474-487, 2018
Cancer size, histotype, and cellular grade may limit the success of fine‐needle aspiration cytology for screen‐detected breast carcinoma
E Manfrin, F Falsirollo, A Remo, D Reghellin, R Mariotto, D Dalfior, ...
Cancer Cytopathology: A Journal of the American Cancer Society 117 (6), 491-499, 2009
The system can't perform the operation now. Try again later.
Articles 1–20